Ionis Pharmaceuticals, Inc. (IONS) Return on equity 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-78.0%FY2025 · since FY2016: -60.7% → -78.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -78.0% | -0.8 pp |
| FY2024 | -77.1% | +17.6 pp |
| FY2023 | -94.7% | -47.6 pp |
| FY2022 | -47.1% | -43.4 pp |
| FY2021 | -3.7% | +56.1 pp |
| FY2020 | -59.8% | -78.7 pp |
| FY2019 | 18.9% | -7.2 pp |
| FY2018 | 26.1% | +26.0 pp |
| FY2017 | 0.1% | +60.8 pp |
| FY2016 | -60.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice